Please assess the completion status of the following clinical trial:

Trial Title: First Line Chemotherapy for Advanced Cancer

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Inoperable locally advanced, recurrent, and/or metastatic adenocarcinoma of the stomach or gastro-esophageal junction~* Adult patients \>=18 years of age~* Performance Status- Eastern Cooperative Oncology Group (ECOG) 0-2;~* At least have one measurable disease(according to RECIST)~* Adequate bone marrow,renal and liver function~Exclusion Criteria:~* Previous chemotherapy for advanced/metastatic disease~* Lack of physical integrity of the upper gastrointestinal tract, or malabsorption syndrome

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- albumin-bounded paclitaxel plus S-1 (Type: EXPERIMENTAL): arm 1:albumin-bounded paclitaxel 200mg iv d1 and S-1 80mg/m2/d po d1-10, repeated every 2 weeks,up to 9 cycles,then S-1 as single agent to treat to disease progression

Based on this trial design, predict the completion outcome and termination type (if applicable).